An interventional study of PAIN REDUCTION ON VAS/NRS in Lumbar Facet Joint Pain and Lumbar Medial Branch Neurotomy, sponsored by Instituto de Investigación Hospital Universitario La Paz. Completed at 1 site in Spain. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2020-01-18.
Sponsored by Instituto de Investigación Hospital Universitario La Paz · Not applicable, Interventional, and Treatment
Among 31 studies in Arthralgia with a site in Spain — 7 open to participants now, 8 under way, 1 of them phase 3. Arthralgia · Spain.
Among the 31 studies in Arthralgia with a site in Spain, this one is the 15th largest by enrollment of the 24 interventional ones that give a count, is one of 4 that started in 2018, is one of 13 with no phase, and was the 8th registered.
277 studies on the registry are indexed under Arthralgia; 54 are open to participants now.
Browse Arthralgia studies →7 of the 31 studies in Arthralgia with a site in Spain are open now. Recruiting first, the newest first:
Universidad Católica San Antonio de Murcia · Sites in Spain
Ages 31+
Fundació Eurecat · Sites in Spain
Ages 40–70
Investigación en Hemofilia y Fisioterapia · Sites in Spain
Ages 18–65 · Men only · Healthy volunteers
Fundación Universidad Católica de Valencia San Vicente Mártir · Sites in Spain
Ages 16+
Olatec Therapeutics, Inc. · Sites in Spain, United States, France and 2 more countries
Ages 18+
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 35 Arthralgia studies recruiting now, 18 (51%) set no upper age limit and 16 (46%) stop at 75 or younger; 1 takes children under 18; 9 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
31 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 4 · Phase 3 7 · Phase 4 1
First in 2006; this study’s year is marked. 4 started in 2018.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 43 is below the median of 73 across 218 interventional studies indexed under Arthralgia.
Median enrollment 78 across the 24 interventional studies, 60 across the 7 observational. Of the 19 that completed or were terminated, 5 (26%) have results posted.
This tab as a report to print or save as PDF → With an account.
11 of 31 have an industry lead sponsor. The 10 most frequent:
Instituto de Investigación Hospital Universitario La Paz is the lead sponsor of 104 studies on the registry; 14 are open to participants now.
Instituto de Investigación Hospital Universitario La Paz has 1 study filed under Arthralgia — fewer than ten, so there is no comparison to draw.
3 of the studies in Arthralgia with a site in Spain that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05658575Phase 3Olatec Therapeutics, Inc.Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare | 2026-12-31 |
| NCT07318896Fundació EurecatEffect of Agar/Collagen-based Compounds on Osteoarticular Pain: Randomized Triple-blind Clinical Trial | 2027-02 |
| NCT07870967Universidad Católica San Antonio de MurciaUndenatured Type II Collagen for Knee Osteoarthritis Pain | 2027-07 |
Add all 3 to your calendar (.ics) → With an account.
Among the 31 studies in Arthralgia with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Prospective study to analyse pain reduction with two types of canulae and two types of placements for lumbar medial branch radiofrequency denervation.
Patients who suffer from lumbar zygapophyseal joint pain often receive radiofrequency medial branch denervation as treatment. Many types if canulae exist, and many types of placing them in relation to the Medial Branch nerves (MB). The EARL study tries to compare the analgesic effect of thin canulae (22 gauge) placed perpendicular to MB to thicker canulae (18 gauge) placed parallel to MB.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Thick canulae (18 gauge) placed parallel to Medial Branch under fluoroscopy.
Other: PAIN REDUCTION ON VAS/NRS
Thin canulae (22 gauge) placed perpendicular to Medial Branch under fluoroscopy.
Other: PAIN REDUCTION ON VAS/NRS
Pain reduction comparing two different techniques and canulae placement, under fluoroscopic guidance.
PAIN REDUCTION ON VAS/NRS
Reduction in pain, at 1,3 and 6 months
Time frame: 1-3-6 months
OSWESTRY DISABILITY INDEX
Quantify disability for low back pain.
Time frame: 1-3-6 months
ROLAND MORRIS
Health status measure for low back pain
Time frame: 1-3-6 months
MEDICATION REDUCTION
Pain medication reduction
Time frame: 1-3-6 months
WORKING STATUS
CHANGE IN WORKING STATUS
Time frame: 1-3-6 months
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Mar 2018 to primary completion in Dec 2019, 21 months.
Of 64 non-industry interventional studies with no phase under Arthralgia, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 31. This study's 21 months is above that.
Counting every sponsor, half of 82 studies reached it within 14 months; a quarter within 4 and three quarters within 29.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Instituto de Investigación Hospital Universitario La Paz →